Citigroup Inc Sana Biotechnology, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Citigroup Inc holds 161,561 shares of SANA stock, worth $502,454. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,561
Previous 314,569
48.64%
Holding current value
$502,454
Previous $528,000
16.48%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SANA
# of Institutions
168Shares Held
108MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$77.8 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$34.4 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$31.6 Million0.02% of portfolio
-
Baillie Gifford & CO10.1MShares$31.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.61MShares$23.7 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $592M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...